JP2016519101A5 - - Google Patents

Download PDF

Info

Publication number
JP2016519101A5
JP2016519101A5 JP2016505926A JP2016505926A JP2016519101A5 JP 2016519101 A5 JP2016519101 A5 JP 2016519101A5 JP 2016505926 A JP2016505926 A JP 2016505926A JP 2016505926 A JP2016505926 A JP 2016505926A JP 2016519101 A5 JP2016519101 A5 JP 2016519101A5
Authority
JP
Japan
Prior art keywords
composition
omega
acid
fatty acid
fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016505926A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016519101A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2014/050329 external-priority patent/WO2014162313A1/en
Publication of JP2016519101A publication Critical patent/JP2016519101A/ja
Publication of JP2016519101A5 publication Critical patent/JP2016519101A5/ja
Pending legal-status Critical Current

Links

JP2016505926A 2013-04-04 2014-04-03 オメガ−3脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ Pending JP2016519101A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361808246P 2013-04-04 2013-04-04
US61/808,246 2013-04-04
PCT/IL2014/050329 WO2014162313A1 (en) 2013-04-04 2014-04-03 Anti-inflammatory synergistic combinations comprising omega-3 fatty acid and tomato lycopene

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018224936A Division JP6803898B2 (ja) 2013-04-04 2018-11-30 オメガ−3脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ

Publications (2)

Publication Number Publication Date
JP2016519101A JP2016519101A (ja) 2016-06-30
JP2016519101A5 true JP2016519101A5 (enExample) 2017-05-18

Family

ID=51657661

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016505926A Pending JP2016519101A (ja) 2013-04-04 2014-04-03 オメガ−3脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ
JP2018224936A Expired - Fee Related JP6803898B2 (ja) 2013-04-04 2018-11-30 オメガ−3脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018224936A Expired - Fee Related JP6803898B2 (ja) 2013-04-04 2018-11-30 オメガ−3脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ

Country Status (7)

Country Link
US (2) US9901562B2 (enExample)
EP (1) EP2981256B1 (enExample)
JP (2) JP2016519101A (enExample)
CN (1) CN105407885B (enExample)
AU (1) AU2014246728B2 (enExample)
ES (1) ES2932248T3 (enExample)
WO (1) WO2014162313A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9901562B2 (en) * 2013-04-04 2018-02-27 Lycored Ltd. Anti-inflammatory omega-3 synergistic combinations
CN108354919A (zh) * 2017-12-29 2018-08-03 广东海洋大学 一种用于提高抗氧化功能的不饱和脂肪酸组合物及其应用
CN111053248A (zh) * 2018-10-16 2020-04-24 东莞市维康医疗投资有限公司 一种地龙蛋白口服液及其制备方法
US11707497B2 (en) 2019-10-09 2023-07-25 Brain Health Holding Llc Methods and compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil providing anti-inflammatory effects and neuroprotection for disease states
CA3153891A1 (en) 2019-10-09 2021-04-15 Gregory CUMBERFORD Compositions with purified bombyx mori cocoon silk peptide fiber and refined buglossoides arvensis seed oil, and related methods
CN114786655A (zh) * 2019-10-10 2022-07-22 乐康瑞德有限公司 用于抑制胶原蛋白流失的组合物和方法
US12582692B2 (en) * 2024-01-03 2026-03-24 Hazel's Holistic, Llc Methods and kits for reducing microplastics levels and/or reducing or minimizing microplastics accumulation rates in subjects

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837311A (en) 1993-12-13 1998-11-17 Makhteshim Chemical Works Ltd. Industrial processing of tomatoes and product thereof
DK0938846T3 (da) 1998-02-13 2004-06-14 Nestle Sa Garneret toast
US20020146400A1 (en) * 2000-01-07 2002-10-10 Cincotta Anthony H. Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity
EP1476143A1 (en) 2002-02-15 2004-11-17 DSM IP Assets B.V. Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
KR20090027204A (ko) 2006-05-15 2009-03-16 디에스엠 아이피 어셋츠 비.브이. 전립선 암종에 대한 신규 활성제
KR20090109793A (ko) * 2008-04-16 2009-10-21 홉킨스바이오연구센터(주) 크랜베리 추출물 또는 복분자 추출물을 함유하는건강기능성식품 조성물
PL2381935T3 (pl) 2009-01-19 2016-11-30 Synergiczne połączenia karotenoidów i polifenoli
US20110008901A1 (en) 2009-07-07 2011-01-13 Kiernan Urban A Apolipoprotein ciii in pre- and type 2 diabetes
WO2011057183A1 (en) 2009-11-06 2011-05-12 Alcon Research, Ltd. Nutritional supplements for relief of dry eye
PL2976070T3 (pl) * 2013-03-19 2021-12-27 Lycored Ltd. Przeciwzapalne synergistyczne kombinacje astaksantyny z likopenem i kwasem karnozowym
US9901562B2 (en) * 2013-04-04 2018-02-27 Lycored Ltd. Anti-inflammatory omega-3 synergistic combinations

Similar Documents

Publication Publication Date Title
ES2666322T3 (es) Composiciones farmacéuticas para el tratamiento de trastornos musculares
CO2017005626A2 (es) Una composición que comprende bacteroides thetaiotaomicron
CO7121328A2 (es) Composiciones de ester de ácido graso omega -3
UA114615C2 (uk) Збагачена дпк композиція омега-3 поліненасичених жирних кислот у формі вільної кислоти
CL2017001614A1 (es) Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados
EP3171871C0 (en) SOLID DOSAGE FORM COMPOSITION FOR BUCCAL OR SUBLINGUAL ADMINISTRATION OF CANNABINOIDS
MX2017007266A (es) Implemento para el cuidado bucal con un mango de componentes multiples.
DK3149105T3 (da) Anvendelse af syntetiske syresammensætninger som alternativer til konventionelle syrer i olie- og gasindustrien
CR20170320A (es) Mezcla de ácidos carboxílicos para tratar pacientes con insuficiencia renal
WO2014165190A3 (en) Compositions comprising docosapentaenoic acid and methods of use
CY1123942T1 (el) Συνθεσεις ωμεγα-3 λιπαρων οξεων για τη θεραπεια ασθενειων που επιφερουν βλαβη στο νευρικο συστημα
AR097146A1 (es) Composición para alimentación de rumiantes y método para prepararla
GEP201606568B (en) Compositions for the treatment of neurologic disorders
JP2014505702A5 (enExample)
MX2016011290A (es) Composiciones de ester de colina de acido lipoico y metodos de uso.
CL2017001613A1 (es) Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-6 poliinsaturados
ZA201702385B (en) Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
MX2015017457A (es) Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento de inflamacion.
CO2017001088A2 (es) Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas
PL3784044T3 (pl) Kompozycje wielonienasyconych kwasów tłuszczowych wzbogacone w dha
WO2016040570A3 (en) Dietary emulsion formulations and methods for using the same
BR112016028518A2 (pt) composições farmacêuticas que compreendem dgla e uso do mesmo
PL3809858T3 (pl) Kompozycje wielonienasyconych kwasów tłuszczowych wzbogacone w dha
EP2981256A4 (en) INFLAMMATORY SYNERGISTIC COMBINATIONS WITH OMEGA-3 FATTY ACID AND TOMATO LYCOPINE
BR112016028561A8 (pt) composição e forma de dosagem compreendendo um óleo marinho que compreende ácidos graxos, e, uso das mesmas